8 Red Days In A Row: Veeva Systems Stock Is Down 14%

VEEVYTD+19.3%SPYYTD+1.9%XLVYTD+15.9%
Analyze VEEV →

Today’s big story: Will 2027 Be A 2022 Repeat For Stocks?

Veeva Systems (VEEV) stock has fallen for 8 consecutive trading days, losing 14.2% over that stretch. That erased about $7.1 billion from the company’s market value, which now stands at about $42.7 billion. The stock closed at $262.92 on Thursday, November 19, 18.6% below its 52-week high of $323.04 and 73.6% above its low of $151.43.

Image from Pixabay

 
The Streak Next To The S&P 500

Returns for VEEV and the S&P 500 over the streak and the periods around it, all ending Thursday, November 19 and including dividends:
 

Return Period VEEV S&P 500
1 Day -5.2% -2.0%
8 Days (Current Streak) -14.2% -4.9%
1 Month (21 Trading Days) -18.0% -7.4%
3 Months (63 Trading Days) 6.1% -6.2%
Year To Date 17.8% 5.9%
1 Year (252 Trading Days) -3.9% 9.7%

A Stock-Specific Slide, Or A Market Move?

Over the same 8 trading days, the S&P 500 returned -4.9% including dividends, so the slide is mostly Veeva Systems’ own story rather than the market’s. 2 other S&P 500 stocks are currently on losing streaks of 8 days or longer. Over the past three months the stock is up 6.1%, a window that includes the streak; over the other 55 sessions of that window it was up 23.6%.

What The Numbers Say About The Slide

On the fundamentals, revenue grew 16.5% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; its operating margin is 29.9%, versus a median of 17.4%; and the stock trades at 42.1 times trailing earnings against a median of 30.2. The read is mixed.

If the drop has you weighing an entry, resist buying on price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still hold up.

For anyone who would rather back the theme than one company, a U.S. healthcare providers ETF like IHF holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.

A Slide Like This Is Why Diversification Exists

Watching one stock fall day after day is the clearest lesson the market teaches about single-name risk. Whether this particular decline is an opportunity or a warning, the deeper point is the same: no one name should be able to do this to your portfolio.

The Trefis High Quality (HQ) Portfolio is built on that principle: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Study the slide; spread the risk.